期刊文献+

运动增加肥胖和2型糖尿病患者体内GLP-1水平的机制及意义 被引量:8

Mechanism and significance of exercise-induced increase of GLP-1 in obesity and type 2 diabetes
原文传递
导出
摘要 胰高血糖素样肽-1(glucagon-like peptide-1,GLP-1)的减少在肥胖和2型糖尿病(type 2 diabetes mellitus,T2DM)中的重要作用为运动降低体重和血糖、改善胰岛素敏感性,以及防治肥胖及T2DM的机制研究提供了一个新视角。近年来的研究发现,运动可能通过谷氨酰胺(glutamine,Gln)、白介素-6(interleukin-6,IL-6)、游离脂肪酸(free fatty acid,FFA)、交感-肾上腺髓质系统介导GLP-1的增加。增加的GLP-1可发挥改善胰岛β细胞功能,促进β细胞增殖、抑制β细胞凋亡、抑制食欲和胃排空以及降低chemerin等作用,从而提高胰岛素敏感性、减少能量摄入和改善血糖水平。这可能是运动防治肥胖、T2DM的机制之一,但仍需更多研究证实。该文就运动增加肥胖和2型糖尿病患者体内GLP-1水平的作用、机制及其生物学意义做一综述。 The important role of decreased glucagon-like peptide-1(GLP-1)in obesity and type 2 diabetes mellitus(T2DM)provides a new perspective for the mechanisms of exercise-induced reductions of weight and plasma glucose,improvement of insulin sensitivity,as well as prevention and treatment of obesity and T2DM.Recent studies have found that exercise induced the increase of GLP-1 through the mediation of glutamine(Gln),interleukin-6(IL-6),free fatty acids(FFA),and the sympathetic-adrenal medulla system.The increased GLP-1 resulted in the improved function of isletβcell,pro-proliferation and anti-apoptosis ofβcell,suppressed appetite,inhibited gastric emptying and reduced chemerin,thus increasing insulin sensitivity,reducing energy intake and plasma glucose levels.This may be one of the mechanisms of exercise-mediated preventing and treating obesity and T2DM,but needs to be further confirmed.This article summarized the role of exercise-induced increase of GLP-1 in obesity and T2DM and its significance and mechanism.
作者 张奇龙 王晓慧 ZHANG Qi-Long;WANG Xiao-Hui(School of Kinesiology,Shanghai University of Sport,Shanghai 200438,China)
出处 《生命科学》 CSCD 北大核心 2020年第9期963-971,共9页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(31872801) 上海市人类运动能力开发与保障重点实验室(上海体育学院)(11DZ2261100)。
关键词 GLP-1 运动 肥胖 2型糖尿病 GLP-1 exercise obesity type 2 diabetes mellitus
  • 相关文献

参考文献10

二级参考文献156

  • 1戴霞,陈青云,薛月桂,陈莹,游越西,周爱民,林健云.糖尿病运动处方的开发及量化测评[J].广西医学院学报,2008,18(2):224-226. 被引量:21
  • 2龙碧波,姜海明.运动对谷氨酰胺和免疫的影响[J].中国临床康复,2005,9(8):175-177. 被引量:15
  • 3刘承宜,朱平.激光功能医学及其应用[M].香港:精英出版社,2011:53-413.
  • 4Greenfield J R, Farooqi I S, Keogh J M, et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects[J]. Am J Clin Nutr, 2009, 89(1): 106-113.
  • 5Ahr6n B. The dynamic incretin adaptation and type 2 diabetes[J]. J Clin Endocrinol Metab, 2011, 96(3): 620-622.
  • 6Holz G G, Chepurny O G. Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus[J]. Curr Med Chem, 2003, 10(22): 2471-2483.
  • 7Vilsboll T, Hoist J J. Incretins, insulin secretion and Type 2 diabetes mellitus[J]. Diabetologia, 2004, 47(3): 357-366.
  • 8Watford M. Glutamine metabolism and function in relation to proline synthesis and the safety of glutamine and proline supplementation[J]. J Nutr, 2008, 138(10): 2003S-2007S.
  • 9Oliveira G P, Dias C M, Pelosi P, et al. Understanding the mechanisms of glutamine action in critically ill patients[J]. An Acad Bras Cienc, 2010, 82(2): 417-430.
  • 10Mat6s J M, P6rez-G6mez C, Nflfiez de Castro I, et al. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death[J]. Int J Biochem Cell Biol, 2002, 34(5): 439-458.

共引文献72

同被引文献77

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部